Literature DB >> 19080281

Endoscopic thyroidectomy: an evidence-based research on feasibility, safety and clinical effectiveness.

Xiao-dong Chen1, Bing Peng, Ri-xiang Gong, Li Wang, Bo Liao, Chun-lin Li.   

Abstract

BACKGROUND: The feasibility and safety of endoscopic thyroidectomy were evaluated by an approach of systematic review of published studies in the past decade.
METHODS: A database searching was performed on MEDLINE, Cochrane Database of Systematic Reviews, American College of Physicians Journal Club, Database of Abstracts of Reviews of Effects, Cochrane Central Register of Controlled Trials. Both comparative and non-comparative studies about endoscopic thyroidectomy were selected and analyzed. For the comparative studies, RevMan 4.2 was used for statistical analysis; and for the non-comparative studies, data analysis was performed by SPSS 13.0.
RESULTS: Seven comparative studies involving 367 patients (video-assisted thyroidectomy (VAT), 174 patients; conventional thyroidectomy (CT), 193 patients) were included in VAT-CT group. Age, gender, operative types, and pathological diagnosis were similar. Compared with CT, the mean operative time for VAT was significantly longer (VAT, 80.0 minutes; CT, 61.9 minutes, P < 0.01), but the postoperative hospital stay was shorter (VAT, 1.7 days; CT, 2.5 days, P < 0.01). The complication rate for VAT was 6.9%, while that for CT was 9.3% (P = 0.35). Three studies analyzed the postoperative pain and cosmetic evaluation, and indicated that the VAT group was superior to the CT group, but there was no significant difference after a meta-analysis. Three comparative studies involving 273 patients (totally endoscopic thyroidectomy (TET), 145 patients; CT, 128 patients) were included in TET-CT group and the results generally resembled that of VAT-CT group. There were 18 and 14 non-comparative studies reporting the results of VAT and TET, respectively. The mean operative time for VAT was 76.8 minutes compared with 135.8 minutes for TET. The postoperative hospital stay was 1.8 and 3.8 days for VAT and TET respectively. The rates of conversion to open surgery for VAT and TET were similar (VAT, 2.8%; TET, 3.9%, P = 0.105). The complication rate for VAT was 8.6%, while that for TET was 3.5% (P < 0.01).
CONCLUSIONS: The feasibility and safety of endoscopic thyroidectomy were initially verified and accepted, and it should be considered as a valid option, offering some advantages to patients in terms of cosmetic results and postoperative distress.

Entities:  

Mesh:

Year:  2008        PMID: 19080281

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  6 in total

Review 1.  Minimally invasive video-assisted versus conventional open thyroidectomy: a systematic review of available data.

Authors:  Jiao Liu; Turun Song; Mingqing Xu
Journal:  Surg Today       Date:  2012-02-07       Impact factor: 2.549

2.  The patterns and treatment of postoperative hemorrhage and hematoma in total endoscopic thyroidectomy via breast approach: experience of 1932 cases.

Authors:  Qiu-Ping Xie; Cheng Xiang; Yong Wang; Hai-Chao Yan; Qun-Zi Zhao; Xing Yu; Mao-Lin Zhang; Ping Wang
Journal:  Endocrine       Date:  2019-01-16       Impact factor: 3.633

3.  Thyroidectomy Using the Lateral Cervical Small Incision Approach for Early Thyroid Cancer.

Authors:  Xi-Xin Jin; Qian-Yu Zhang; Chao Gao; Wen-Xin Wei; Chong Jiao; Li Li; Bin-Lin Ma; Chao Dong
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-04-20

4.  Subcutaneous dissection area contributes less to endoscopic thyroidectomy-related invasiveness.

Authors:  Wei Zhang; Qing-Hua Wu; Zhi-Guo Jiang; Ming Qiu
Journal:  Surg Endosc       Date:  2016-01-07       Impact factor: 4.584

5.  Robotic thyroidectomy versus endoscopic thyroidectomy: a meta-analysis.

Authors:  Shuang Lin; Zhi-Heng Chen; Hong-Gang Jiang; Ji-Ren Yu
Journal:  World J Surg Oncol       Date:  2012-11-09       Impact factor: 2.754

6.  Minimally invasive video-assisted thyroidectomy for the early-stage differential thyroid carcinoma.

Authors:  Jian-jun Yu; Shan-lin Bao; Sheng-lin Yu; Da-Qing Zhang; Wings T Y Loo; Louis W C Chow; Li Su; Zhen Cui; Kai Chen; Li-Qiong Ma; Ning Zhang; Hui Yu; Yun-Zhen Yang; Yu Dong; Adrian Y S Yip; Elizabeth L Y Ng
Journal:  J Transl Med       Date:  2012-09-19       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.